Clear Creek Financial Management, LLC Verastem, Inc. Transaction History

Clear Creek Financial Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$0.92 - $11.16 $4,495 - $54,527	4,886 Added 6.41%	81,122 $69,000
Q2 2022 Jul 27, 2022	BUY	$1.02 - $1.83 $77,760 - $139,511	76,236 New	76,236 $88,000
Q1 2022 May 02, 2022	SELL	$1.06 - $2.1 $19,728 - $39,085	-18,612 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$2.05 - $3.2 $38,154 - $59,558	18,612 New	18,612 $38,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Clear Creek Financial Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Creek Financial Management, LLC with notifications on news.